Notably, overexpression of NSUN2-WT but not NSUN2-DM significantly shortened survival of the tumor-bearing mice (p = 0.0233) and decreased efficacy of gefitinib treatment compared to Mock group (Fig. 2f). Here, NSUN2 is linked to neoplasm.